Rhythm Biosciences, a Melbourne‑based biotech firm, pioneers early colorectal cancer diagnostics—innovating tools that could transform patient outcomes and the Australian healthcare market.

Rhythm Biosciences Ltd, a medical diagnostics company focused on early colorectal cancer detection, faces financial challenges and market volatility despite its commendable mission.